CLINICAL_TRIALS trial_result · 2012-05-28

Clinical Trial Update: Early Airway Response to Allergen in Asthmatics (MK-0000-176) [Phase 1]

Phase 1 trial MK-0000-176 evaluating early airway response to allergen in asthmatics; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Merck Sharp & Dohme LLC | Conditions: Asthma | Phase 1 | Status: COMPLETED | Results posted: 2012-05-28